Biobanking Market Report

RA01868

Biobanking Market, by Application (Regenerative Medicines, Life Science, Others), Setting (Academic Medical Institutions, Pharmaceutical and Biotechnology Companies): Global Opportunity Analysis and Industry Forecast, 2020-2027

RA01868

Pages: 170

Feb 2023

The global biobanking market is estimated to surpass $3,929.4 million by 2027, exhibiting a CAGR of 7.8% from 2020 to 2027.

The report provides all-inclusive analysis of global biobanking market with comprehensive study of the various facets of the market including market dynamics, major segments and regions, top leading players, and competitive landscape.

HIGHLIGHTS OF THE REPORT

This report is a compilation of insights acquired via a detailed study and valid inputs from industry experts & industry participants across the value chain and quantitative & qualitative assessment by analysts of the industry

The report provides a comprehensive analysis along with the current trends of the market during the forecast period from 2020 to 2027 to identify & comprehend the prevailing opportunities and the strategic assessment of the global biobanking market growth

The report studies the market from 2019 to 2027 and maps the qualitative impact of several industry factors on market segments as well as geographies

The report provides market estimations and size which is based on in-depth analysis of recent & key developments in the biobanking market

The development strategies implemented by the key industry players are conscripted in the report to understand the competitive scenario of the global biobanking market

WHAT DOES THE REPORT OFFER?

The report emphasizes current market scenario and future trends of the global biobanking market which are gleaned from the impact of various market dynamics such as drivers, challenges & restraints, lucrative opportunities. The report also highlights the key forces that are shaping the market.

In addition, the report provides market size and forecast scrutinizing the global biobanking market through different segments. The report highlights the geographical market scenario of each of the segments thoroughly studied at regional as well as country level to get clearer picture of the global biobanking market. In the report, the global biobanking market is divided into four major regions including North America, Europe, Asia-Pacific, and LAMEA. These regions are further divided into major countries to cover the biobanking market landscape in respective regions.

Furthermore, competitive scenario of the global biobanking market is covered in the report. Major players functioning in the global biobanking market are also studied to understand their position and competitive strengths in the industry. The major company profiles covered in the report include various company’s datum such as brief overview, recent financials, main executives, adoption of key growth strategies, novel advancements or initiatives to sustain and expand their position in the global biobanking market, and others.

MAIN SEGMENTS OF THE MARKET

The market has been categorized based on the following segments for the convenience of research:

Application: Regenerative Medicines, Life Science, Others

Setting: Academic Medical Institutions, Pharmaceutical and Biotechnology Companies

Region:

The global biobanking market is divided into North America, Europe, Asia Pacific, and LAMEA.

The above-mentioned regions are further divided in countries as follows:

North America
- U.S.
- Canada
- Mexico

Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe

Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific

LAMEA
- Brazil
- Argentina
- Saudi Arabia
- South Africa
- UAE
- Rest of LAMEA

KEY MARKET PLAYERS

The report mentions the major players operating in the global biobanking market that focus on advancements & innovations, partnerships, geographical expansion, and product portfolios to obtain a competitive edge in the market space. The major players enlisted in the report include Brooks Life Sciences, BBL, Thermo Fisher Scientific Inc., UK Biobank.

The report summarizes various aspects of all these key players that include as follows:

1. Medizinische Universit

1. RESEARCH METHODOLOGY
- 1.1. Desk Research
- 1.2. Real time insights and validation
- 1.3. Forecast model
- 1.4. Assumptions and forecast parameters
- 1.5. Market size estimation
  - 1.5.1. Top-down approach
  - 1.5.2. Bottom-up approach
2. REPORT SCOPE
- 2.1. Market definition
- 2.2. Key objectives of the study
- 2.3. Report overview
- 2.4. Market segmentation
- 2.5. Overview of the impact of COVID-19 on Global Biobanking Market
3. EXECUTIVE SUMMARY
4. MARKET OVERVIEW
- 4.1. Introduction
- 4.2. Growth impact forces
  - 4.2.1. Drivers
  - 4.2.2. Restraints
  - 4.2.3. Opportunities
- 4.3. Market value chain analysis
  - 4.3.1. List of raw material suppliers
  - 4.3.2. List of manufacturers
  - 4.3.3. List of distributors
- 4.4. Innovation & sustainability matrices
  - 4.4.1. Technology matrix
  - 4.4.2. Regulatory matrix
- 4.5. Porter’s five forces analysis
  - 4.5.1. Bargaining power of suppliers
  - 4.5.2. Bargaining power of consumers
  - 4.5.3. Threat of substitutes
  - 4.5.4. Threat of new entrants
  - 4.5.5. Competitive rivalry intensity
- 4.6. PESTLE analysis
  - 4.6.1. Political
  - 4.6.2. Economical
  - 4.6.3. Social
  - 4.6.4. Technological
  - 4.6.5. Environmental
- 4.7. Impact of COVID-19 on Biobanking Market
  - 4.7.1. Pre-covid market scenario
  - 4.7.2. Post-covid market scenario
5. Biobanking Market, By Technology
- 5.1. Overview
- 5.2 Regenerative Medicines
  - 5.2.1 Definition, key trends, growth factors, and opportunities
  - 5.2.2 Market size analysis, by region, 2020-2027
  - 5.2.3 Market share analysis, by country, 2020-2027
- 5.3 Life Science
  - 5.3.1 Definition, key trends, growth factors, and opportunities
  - 5.3.2 Market size analysis, by region, 2020-2027
  - 5.3.3 Market share analysis, by country, 2020-2027
- 5.4 Others
  - 5.4.1 Definition, key trends, growth factors, and opportunities
  - 5.4.2 Market size analysis, by region, 2020-2027
  - 5.4.3 Market share analysis, by country, 2020-2027
- 5.5 Research Dive Exclusive Insights
  - 5.5.1 Market attractiveness
  - 5.5.2 Competition heatmap
6. Biobanking Market, By Type
- 6.1. Overview
- 6.2 Academic Medical Institutions
  - 6.2.1 Definition, key trends, growth factors, and opportunities
  - 6.2.2 Market size analysis, by region, 2020-2027
  - 6.2.3 Market share analysis, by country, 2020-2027
- 6.3 Pharmaceutical and Biotechnology Companies
  - 6.3.1 Definition, key trends, growth factors, and opportunities
  - 6.3.2 Market size analysis, by region, 2020-2027
  - 6.3.3 Market share analysis, by country, 2020-2027
- 6.4 Research Dive Exclusive Insights
  - 6.4.1 Market attractiveness
  - 6.4.2 Competition heatmap
7. Biobanking Market, By Region
- 7.1 North America
  - 7.1.1 U.S
    - 7.1.1.1 Market size analysis, By Technology, 2020-2027
    - 7.1.1.2 Market size analysis, By Type, 2020-2027
  - 7.1.2 Canada
    - 7.1.2.1 Market size analysis, By Technology, 2020-2027
    - 7.1.2.2 Market size analysis, By Type, 2020-2027
  - 7.1.3 Mexico
    - 7.1.3.1 Market size analysis, By Technology, 2020-2027
    - 7.1.3.2 Market size analysis, By Type, 2020-2027
  - 7.1.4 Research Dive Exclusive Insights
    - 7.1.4.1 Market attractiveness
    - 7.1.4.2 Competition heatmap
- 7.2 Europe
  - 7.2.1 Germany
    - 7.2.1.1 Market size analysis, By Technology, 2020-2027
    - 7.2.1.2 Market size analysis, By Type, 2020-2027
  - 7.2.2 UK
    - 7.2.2.1 Market size analysis, By Technology, 2020-2027
    - 7.2.2.2 Market size analysis, By Type, 2020-2027
  - 7.2.3 France
    - 7.2.3.1 Market size analysis, By Technology, 2020-2027
    - 7.2.3.2 Market size analysis, By Type, 2020-2027
  - 7.2.4 Spain
    - 7.2.4.1 Market size analysis, By Technology, 2020-2027
    - 7.2.4.2 Market size analysis, By Type, 2020-2027
  - 7.2.5 Italy
    - 7.2.5.1 Market size analysis, By Technology, 2020-2027
    - 7.2.5.2 Market size analysis, By Type, 2020-2027
  - 7.2.6 Rest of Europe
    - 7.2.6.1 Market size analysis, By Technology, 2020-2027
    - 7.2.6.2 Market size analysis, By Type, 2020-2027
  - 7.2.7 Research Dive Exclusive Insights
    - 7.2.7.1 Market attractiveness
    - 7.2.7.2 Competition heatmap
- 7.3 Asia-Pacific
  - 7.3.1 China
    - 7.3.1.1 Market size analysis, By Technology, 2020-2027
    - 7.3.1.2 Market size analysis, By Type, 2020-2027
  - 7.3.2 Japan
    - 7.3.2.1 Market size analysis, By Technology, 2020-2027
    - 7.3.2.2 Market size analysis, By Type, 2020-2027
  - 7.3.3 India
    - 7.3.3.1 Market size analysis, By Technology, 2020-2027
    - 7.3.3.2 Market size analysis, By Type, 2020-2027
  - 7.3.4 Australia
    - 7.3.4.1 Market size analysis, By Technology, 2020-2027
    - 7.3.4.2 Market size analysis, By Type, 2020-2027
  - 7.3.5 South Korea
    - 7.3.5.1 Market size analysis, By Technology, 2020-2027
    - 7.3.5.2 Market size analysis, By Type, 2020-2027
  - 7.3.6 Rest of Asia-Pacific
    - 7.3.6.1 Market size analysis, By Technology, 2020-2027
    - 7.3.6.2 Market size analysis, By Type, 2020-2027
  - 7.3.7 Research Dive Exclusive Insights
    - 7.3.7.1 Market attractiveness
    - 7.3.7.2 Competition heatmap
- 7.4 LAMEA
  - 7.4.1 Brazil
    - 7.4.1.1 Market size analysis, By Technology, 2020-2027
    - 7.4.1.2 Market size analysis, By Type, 2020-2027
  - 7.4.2 Saudi Arabia
    - 7.4.2.1 Market size analysis, By Technology, 2020-2027
    - 7.4.2.2 Market size analysis, By Type, 2020-2027
  - 7.4.3 UAE
    - 7.4.3.1 Market size analysis, By Technology, 2020-2027
    - 7.4.3.2 Market size analysis, By Type, 2020-2027
  - 7.4.4 South Africa
    - 7.4.4.1 Market size analysis, By Technology, 2020-2027
    - 7.4.4.2 Market size analysis, By Type, 2020-2027
  - 7.4.5 Rest of LAMEA
    - 7.4.5.1 Market size analysis, By Technology, 2020-2027
    - 7.4.5.2 Market size analysis, By Type, 2020-2027
  - 7.4.6 Research Dive Exclusive Insights
    - 7.4.6.1 Market attractiveness
    - 7.4.6.2 Competition heatmap
8. Competitive Landscape
- 8.1 Top winning strategies, 2020-2027
  - 8.1.1 By strategy
  - 8.1.2 By year
- 8.2 Strategic overview
- 8.3 Market share analysis, 2020-2027
9. Company Profiles
- 9.1 Medizinische Universität Graz
  - 9.1.1 Overview
  - 9.1.2 Business segments
  - 9.1.3 Product portfolio
  - 9.1.4 Financial performance
  - 9.1.5 Recent developments
  - 9.1.6 SWOT analysis
- 9.2 UK Biobank
  - 9.2.1 Overview
  - 9.2.2 Business segments
  - 9.2.3 Product portfolio
  - 9.2.4 Financial performance
  - 9.2.5 Recent developments
  - 9.2.6 SWOT analysis
- 9.3 Shanghai Zhangjiang Biobank
  - 9.3.1 Overview
  - 9.3.2 Business segments
  - 9.3.3 Product portfolio
  - 9.3.4 Financial performance
  - 9.3.5 Recent developments
  - 9.3.6 SWOT analysis
- 9.4 Isenet Biobanking
  - 9.4.1 Overview
  - 9.4.2 Business segments
  - 9.4.3 Product portfolio
  - 9.4.4 Financial performance
  - 9.4.5 Recent developments
  - 9.4.6 SWOT analysis
- 9.5 Hamilton Company
  - 9.5.1 Overview
  - 9.5.2 Business segments
  - 9.5.3 Product portfolio
  - 9.5.4 Financial performance
  - 9.5.5 Recent developments
  - 9.5.6 SWOT analysis
- 9.6 Thermo Fisher Scientific Inc.
  - 9.6.1 Overview
  - 9.6.2 Business segments
  - 9.6.3 Product portfolio
  - 9.6.4 Financial performance
  - 9.6.5 Recent developments
  - 9.6.6 SWOT analysis
- 9.7 ProMedDx
  - 9.7.1 Overview
  - 9.7.2 Business segments
  - 9.7.3 Product portfolio
  - 9.7.4 Financial performance
  - 9.7.5 Recent developments
  - 9.7.6 SWOT analysis
- 9.8 BBL
  - 9.8.1 Overview
  - 9.8.2 Business segments
  - 9.8.3 Product portfolio
  - 9.8.4 Financial performance
  - 9.8.5 Recent developments
  - 9.8.6 SWOT analysis
- 9.9 Brooks Life Sciences
  - 9.9.1 Overview
  - 9.9.2 Business segments
  - 9.9.3 Product portfolio
  - 9.9.4 Financial performance
  - 9.9.5 Recent developments
  - 9.9.6 SWOT analysis
- 9.10 ASKION
  - 9.10.1 Overview
  - 9.10.2 Business segments
  - 9.10.3 Product portfolio
  - 9.10.4 Financial performance
  - 9.10.5 Recent developments
  - 9.10.6 SWOT analysis

Purchase Options

Individual License $4290 Corporate License $4920

Personalize this research

Triangulate with your own data
Request your format and definition
Get a deeper dive on a specific application, geography, customer or competitor

10% Off on Customization

Speak To The Analyst
Or Schedule A Call

+ 1-888-961-4454 Toll - Free
support@researchdive.com

Biobanking Market Report

Biobanking Market, by Application (Regenerative Medicines, Life Science, Others), Setting (Academic Medical Institutions, Pharmaceutical and Biotechnology Companies): Global Opportunity Analysis and Industry Forecast, 2020-2027

1. RESEARCH METHODOLOGY

1.1. Desk Research

1.2. Real time insights and validation

1.3. Forecast model

1.4. Assumptions and forecast parameters

1.5. Market size estimation

1.5.1. Top-down approach

1.5.2. Bottom-up approach

2. REPORT SCOPE

2.1. Market definition

2.2. Key objectives of the study

2.3. Report overview

2.4. Market segmentation

2.5. Overview of the impact of COVID-19 on Global Biobanking Market

3. EXECUTIVE SUMMARY

4. MARKET OVERVIEW

4.1. Introduction

4.2. Growth impact forces

4.2.1. Drivers

4.2.2. Restraints

4.2.3. Opportunities

4.3. Market value chain analysis

4.3.1. List of raw material suppliers

4.3.2. List of manufacturers

4.3.3. List of distributors

4.4. Innovation & sustainability matrices

4.4.1. Technology matrix

4.4.2. Regulatory matrix

4.5. Porter’s five forces analysis

4.5.1. Bargaining power of suppliers

4.5.2. Bargaining power of consumers

4.5.3. Threat of substitutes

4.5.4. Threat of new entrants

4.5.5. Competitive rivalry intensity

4.6. PESTLE analysis

4.6.1. Political

4.6.2. Economical

4.6.3. Social

4.6.4. Technological

4.6.5. Environmental

4.7. Impact of COVID-19 on Biobanking Market

4.7.1. Pre-covid market scenario

4.7.2. Post-covid market scenario

5. Biobanking Market, By Technology

5.1. Overview

5.2 Regenerative Medicines

5.2.1 Definition, key trends, growth factors, and opportunities

5.2.2 Market size analysis, by region, 2020-2027

5.2.3 Market share analysis, by country, 2020-2027

5.3 Life Science

5.3.1 Definition, key trends, growth factors, and opportunities

5.3.2 Market size analysis, by region, 2020-2027

5.3.3 Market share analysis, by country, 2020-2027

5.4 Others

5.4.1 Definition, key trends, growth factors, and opportunities

5.4.2 Market size analysis, by region, 2020-2027

5.4.3 Market share analysis, by country, 2020-2027

5.5 Research Dive Exclusive Insights

5.5.1 Market attractiveness

5.5.2 Competition heatmap

6. Biobanking Market, By Type

6.1. Overview

6.2 Academic Medical Institutions

6.2.1 Definition, key trends, growth factors, and opportunities

6.2.2 Market size analysis, by region, 2020-2027

6.2.3 Market share analysis, by country, 2020-2027

6.3 Pharmaceutical and Biotechnology Companies

6.3.1 Definition, key trends, growth factors, and opportunities

6.3.2 Market size analysis, by region, 2020-2027

6.3.3 Market share analysis, by country, 2020-2027

6.4 Research Dive Exclusive Insights

6.4.1 Market attractiveness

6.4.2 Competition heatmap

7. Biobanking Market, By Region

7.1 North America

7.1.1 U.S

7.1.1.1 Market size analysis, By Technology, 2020-2027

7.1.1.2 Market size analysis, By Type, 2020-2027